We'll start with ChIP - seq data from the ENCODE project, find
enhancers in embryonic stem cells, and conclude with a targeted CRISPR screen that can disrupt these enhancers.
Not exact matches
Furthermore, by making use of
embryonic stem cells and
in vitro differentiation, SIF - seq can be used to assess
enhancer activity
in a wide variety of disease - relevant
cell types.»
The ability of SIF - seq to use reporter assays
in mouse
embryonic stem cells to identify human
embryonic stem cell enhancers that are not present
in the mouse genome opens the door to intriguing research possibilities as Dickel explains.
«We've shown that SIF - seq can be used to identify
enhancers active
in cardiomyocytes, neural progenitor
cells, and
embryonic stem cells, and we think that it has the potential to be expanded for use
in a much wider variety of
cell types,» Dickel says.
The findings are reported
in the article «A Sox2 distal
enhancer cluster regulates
embryonic stem cell differentiation potential» published online December 15
in Genes & Development.
With the new SIF - seq technique, mouse
embryonic stem cells can be used to identify human
embryonic stem cell enhancers even when the human
enhancers are not present
in the mouse genome.